{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:22:45Z","timestamp":1788870165124,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.lfs.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T13:15:49Z","timestamp":1395062149000},"page":"404-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic factors in pulmonary arterial hypertension with Dana Point group 1"],"prefix":"10.1016","volume":"118","author":[{"given":"Shiro","family":"Adachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.03.002_bb0005","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.amjcard.2012.01.366","article-title":"Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving \u22642years and those surviving \u22655years after baseline right-sided cardiac catheterization","volume":"109","author":"Batal","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lfs.2014.03.002_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2014.03.002_bb0015","doi-asserted-by":"crossref","first-page":"164-U138","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2014.03.002_bb0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ejechocard\/jeq011","article-title":"New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension","volume":"11","author":"Brierre","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.lfs.2014.03.002_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary-hypertension \u2014 results from a national prospective registry","volume":"115","author":"Dalonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lfs.2014.03.002_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.80.2.353","article-title":"Two-dimensional and doppler-echocardiographic and cardiac-catheterization correlates of survival in primary pulmonary-hypertension","volume":"80","author":"Eysmann","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2014.03.002_bb0035","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1378\/chest.12-3033","article-title":"Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage","volume":"144","author":"Fenstad","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2014.03.002_bb0040","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/eurheartj\/eht006","article-title":"Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure","volume":"34","author":"Frohlich","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lfs.2014.03.002_bb0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9149(99)00342-2","article-title":"Frequency and prognostic significance at pericardial effusion in primary pulmonary hypertension","volume":"84","author":"Hinderliter","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lfs.2014.03.002_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2014.03.002_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1378\/chest.10-0227","article-title":"Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases","volume":"140","author":"Luo","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2014.03.002_bb0060","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2014.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension \u2014 the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2014.03.002_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0002-9149(71)90011-7","article-title":"Production of acute pericardial effusion","volume":"28","author":"Miller","year":"1971","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lfs.2014.03.002_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e3181a3936f","article-title":"Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations","volume":"338","author":"Natanzon","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.lfs.2014.03.002_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/ar4051","article-title":"Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study","volume":"14","author":"Ngian","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lfs.2014.03.002_bb0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lfs.2014.03.002_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2169\/internalmedicine.38.12","article-title":"Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980\u20131990","volume":"38","author":"Okada","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.lfs.2014.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echo cardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lfs.2014.03.002_bb0100","first-page":"678","article-title":"Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension","volume":"29","author":"Shimony","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.lfs.2014.03.002_bb0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0025-6196(11)60747-7","article-title":"Wide variation in clinicians' assessment of New York heart Association\/World Health Organization functional class in patients with pulmonary arterial hypertension","volume":"84","author":"Taichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lfs.2014.03.002_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1378\/chest.10-2327","article-title":"Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era","volume":"140","author":"Zhang","year":"2011","journal-title":"Chest"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514003142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514003142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:15:28Z","timestamp":1758399328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514003142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0024320514003142"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors in pulmonary arterial hypertension with Dana Point group 1","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}